FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$2.47
-0.32 (-11.47%)
▼
5d:
-17.39%
30d:
-19.28%
90d:
-31.01%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Smart Money Accumulation
FBIO is down 7.1% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 2,963 OI. Call ratio: 100% View Scanner →
Strength: 8.6/10
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$73.51
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$45.65
94.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $2.47, which is considered oversold relative to its 30-day fair value range of $2.93 to $3.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.6) compared to its historical average (327.7). Remarkably, the market is currently pricing in an annual earnings decline of 82.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $2.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: FBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.75 (+335.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $2.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: FBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.75 (+335.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.93 -
$3.40
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.5%)
- BULLISH: Trading 335.2% below Wall St target ($10.75)
- CAUTION: 5-day price weakness (-17.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$2.93 -
$3.40
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.61
Resistance Level
$3.18
Current Trend
Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.64
Wall Street Target
$10.75
(+335.2%)
Revenue Growth (YoY)
20.5%
Profit Margin
6.4%
Valuation Discount vs History
-82.9% cheaper
PE vs Historical
1.6 vs 327.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-82.9%
(market-implied from PE analysis)
1-Year Target
$2.22
(-10%)
2-Year Target
$2.00
(-19%)
3-Year Target
$1.80
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→328)
$360.73
(+14504%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 15000.0%)
$113.90
(+4511%)
Base:
(SPY PE: 1.6, Growth: 15000.0%)
$8.34
(+238%)
Bear:
(PE: 1.4, Growth: 15000.0%)
$7.09
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.6 to 327.7
Stabilization Target:
$494.83
(+19933.5%)
PE Expansion Potential:
+19933.5%
Share & Embed Analysis
Last updated: April 02, 2026 4:25 AM ET
Data refreshes hourly during market hours. Next update: 5:25 AM
Data refreshes hourly during market hours. Next update: 5:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
